⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25923890 | 0.85 | PRMT3 (0.33) | — | |
| SCHEMBL14578306 | 0.83 | PRMT3 (0.32) | — | |
| SCHEMBL13589014 | 0.82 | — | — | |
| SCHEMBL24607576 | 0.81 | KDM5A (0.36) | — | |
| Methylethylamine SCHEMBL10714659 | 0.76 | PRMT3 (0.33) | — | |
| SCHEMBL14578314 | 0.76 | PRMT3 (0.40) | — | |
| SCHEMBL254237 | 0.75 | — | — | |
| SCHEMBL15919032 | 0.75 | — | — | |
| Dimethylamine SCHEMBL28411659 | 0.74 | — | — | |
| SCHEMBL12901248 | 0.73 | PRMT3 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023086502-A9 | HYDROLYZED PROTEIN SERUM REPLACEMENT COMPOSITIONS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2024-04-18 | — | — | WO | disclosed |
| EP-4328309-A2 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| WO-2024020084-A1 | HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-4212527-A1 | GLP-1R RECEPTOR AGONIST COMPOUND AND USE THEREOF | Suzhou Vincentage Pharma Co., Ltd (CN) | 2023-07-19 | — | — | EP | disclosed |
| WO-2023115165-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023086502-A1 | HYDROLYZED PROTEIN SERUM REPLACEMENT COMPOSITIONS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| WO-2022095960-A1 | KRAS INHIBITORS FOR TREATMENT OF CANCERS | 泰励生物科技（上海）有限公司 | 2022-05-12 | — | — | WO | disclosed |
| WO-2022000443-A1 | METHODS AND COMPOSITIONS FOR TARGETING TREGS USING CCR8 INHIBITORS | Nanjing Immunophage Biotech Co., Ltd. (CN) | 2022-01-06 | — | — | WO | disclosed |
| US-20210113520-A1 | Novel treatment of mitochondrial diseases | KHONDRION IP B.V. (NL) | 2021-04-22 | — | — | US | disclosed |
| EP-3783025-A1 | TARGETED CD73 ANTIBODY AND ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USES THEREOF | Fudan University (CN) | 2021-02-24 | — | — | EP | disclosed |
| US-20140256853-A1 | Curing Agent for Low Temperature Cure Applications | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-11 | — | — | US | disclosed |
| WO-2014100695-A1 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-06-26 | — | — | WO | disclosed |
| US-8735512-B2 | Curing agent for low temperature cure applications | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| EP-2698367-A1 | Benzimidazoles for the treatment of cancer | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2014-02-19 | — | — | EP | disclosed |
| US-8088757-B2 | Betulinol derivatives as anti-cancer agents | BIORINGS LLC (US) | 2012-01-03 | — | — | US | disclosed |
| US-8008280-B2 | Betulinol derivatives as anti-HIV agents | BIORINGS LLC (US) | 2011-08-30 | — | — | US | disclosed |
| US-20090259003-A1 | Curing Agent For Low Temperature Cure Applications | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2009-10-15 | — | — | US | disclosed |
| US-20090176753-A1 | Betulinol derivatives as anti-cancer agents | SAXENA RESEARCH, LLC | 2009-07-09 | — | — | US | disclosed |
| US-20080286291-A1 | Betulinol Derivatives as Anti-Hiv Agents | SAXENA RESEARCH, LLC | 2008-11-20 | — | — | US | disclosed |
| US-20070149521-A1 | Bicyclic protein kinase inhibitors | OSI PHARMACEUTICALS, INC. | 2007-06-28 | — | — | US | disclosed |